These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome. Lopez D, Garcia-Valladares I, Palafox-Sanchez CA, De La Torre IG, Kobayashi K, Matsuura E, Lopez LR. Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048 [Abstract] [Full Text] [Related]
3. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement. Lopez LR, Simpson DF, Hurley BL, Matsuura E. Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973 [Abstract] [Full Text] [Related]
5. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Bruce IN. Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277 [Abstract] [Full Text] [Related]
6. Atherosclerosis in systemic lupus erythematosus. Sherer Y, Zinger H, Shoenfeld Y. Autoimmunity; 2010 Feb; 43(1):98-102. PubMed ID: 20014976 [Abstract] [Full Text] [Related]
7. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis. Kobayashi K, Lopez LR, Shoenfeld Y, Matsuura E. Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986 [Abstract] [Full Text] [Related]
14. Traditional and nontraditional risk factors for atherosclerosis in patients with systemic lupus erythematosus. Pompilian V, Badea C, Dragomanu I, Bălăşescu E, Tănăsescu C. Rom J Intern Med; 2008 Jun; 46(3):195-8. PubMed ID: 19366077 [Abstract] [Full Text] [Related]